AL-S Pharma has released new data from the phase 2 trial evaluating its drug AP-101 in patients with amyotrophic lateral ...

Envision Pharma Group (Envision) has appointed Jay Ferro as President, Technology and Chief Product Officer (CPO). He joins ...

Grifols have announced proof-of-concept data from its Chronos-PD programme, which uses AI, advanced proteomics and real-world ...

Richmond Pharmacology has appointed John Hotti as Chief Technology Officer (CTO), strengthening the company’s leadership in ...

Shionogi has dosed the first patients in the phase 2 clinical trial evaluating S-606001, a potential treatment for late-onset ...

Understanding Neurodiversity Neurodivergence is often mistakenly equated solely with autism. As Prof. Kirby explains, it is a ...

Clasado Biosciences has appointed Sebastian Nummelin as APAC Regional Director. The move strengthens its commercial presence ...

Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that ...

Bladder cancer affects over 224,000 people annually in Europe, with over 30% of cases being muscle-invasive bladder cancer ...

Raguneprocel, a stem cell-based dopamine neuron replacement therapy for treating motor symptoms in Parkinson’s disease (PD), ...

CNX Therapeutics has appointed David Flint as Chief Corporate Development Officer (CCDO). Flint is an experienced M&A and ...

Allergan Aesthetics, an AbbVie company, has launched a unified vocabulary to standardise how skin quality is discussed. The ...